PLRX
Pliant Therapeutics Inc
$12.52
Earnings Summary
Revenue | $4.84Mn |
Net Profits | $-41.11Mn |
Net Profit Margins | -849.36% |
Highlights
Pliant Therapeutics Inc’s revenue jumped 146.31% since last year same period to $4.84Mn in the Q4 2023. On a quarterly growth basis, Pliant Therapeutics Inc has generated +Inf% jump in its revenue since last 3-months.
Pliant Therapeutics Inc’s net profit fell -18.79% since last year same period to $-41.11Mn in the Q4 2023. On a quarterly growth basis, Pliant Therapeutics Inc has generated 0.91% jump in its net profits since last 3-months.
Pliant Therapeutics Inc’s net profit margin jumped 51.77% since last year same period to -849.36% in the Q4 2023. On a quarterly growth basis, Pliant Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Pliant Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.77 |
EPS Estimate Current Year | -0.77 |
Highlights
Pliant Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.77 - a 4.94% jump from last quarter’s estimates.
Pliant Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.77.
Key Ratios
Key ratios of the Pliant Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.69 |
Highlights
Pliant Therapeutics Inc’s earning per share (EPS) jumped 4.17% since last year same period to -0.69 in the Q4 2023. This indicates that the Pliant Therapeutics Inc has generated 4.17% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-09 | -0.71 | -0.7 | 1.41% |
2024-02-27 | -0.81 | -0.69 | 14.81% |
2023-11-09 | -0.77 | -0.7 | 9.09% |
2023-05-09 | -0.67 | -0.67 | 0% |
₹0 US Stocks a/c Opening Fee